Since Ibrutinib displays nM binding even without covalent bond formation (Fig. ), non-covalent BTK PROTACs can be very potent , and adding irreversible covalent binding would primarily be expected to reduce potency due to the loss of catalysis. Indeed, the noncovalent NC-1 was the most potent PROTAC we tested, similarly to Tinworth et al .